chr3-39265745-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001337.4(CX3CR1):c.765G>A(p.Thr255=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00415 in 1,614,186 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0032 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0043 ( 12 hom. )
Consequence
CX3CR1
NM_001337.4 synonymous
NM_001337.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -9.13
Genes affected
CX3CR1 (HGNC:2558): (C-X3-C motif chemokine receptor 1) Fractalkine is a transmembrane protein and chemokine involved in the adhesion and migration of leukocytes. The protein encoded by this gene is a receptor for fractalkine. The encoded protein also is a coreceptor for HIV-1, and some variations in this gene lead to increased susceptibility to HIV-1 infection and rapid progression to AIDS. Four transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 3-39265745-C-T is Benign according to our data. Variant chr3-39265745-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 788850.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-9.13 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CX3CR1 | NM_001337.4 | c.765G>A | p.Thr255= | synonymous_variant | 2/2 | ENST00000399220.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CX3CR1 | ENST00000399220.3 | c.765G>A | p.Thr255= | synonymous_variant | 2/2 | 1 | NM_001337.4 | P1 | |
CX3CR1 | ENST00000358309.3 | c.861G>A | p.Thr287= | synonymous_variant | 2/2 | 2 | |||
CX3CR1 | ENST00000541347.5 | c.765G>A | p.Thr255= | synonymous_variant | 2/2 | 4 | P1 | ||
CX3CR1 | ENST00000542107.5 | c.765G>A | p.Thr255= | synonymous_variant | 2/2 | 4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00317 AC: 482AN: 152194Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
482
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00368 AC: 917AN: 249482Hom.: 4 AF XY: 0.00335 AC XY: 454AN XY: 135350
GnomAD3 exomes
AF:
AC:
917
AN:
249482
Hom.:
AF XY:
AC XY:
454
AN XY:
135350
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00425 AC: 6217AN: 1461874Hom.: 12 Cov.: 33 AF XY: 0.00401 AC XY: 2916AN XY: 727238
GnomAD4 exome
AF:
AC:
6217
AN:
1461874
Hom.:
Cov.:
33
AF XY:
AC XY:
2916
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00316 AC: 482AN: 152312Hom.: 1 Cov.: 32 AF XY: 0.00318 AC XY: 237AN XY: 74474
GnomAD4 genome
AF:
AC:
482
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
237
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 07, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2023 | CX3CR1: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at